Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico M Goodsaid

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Toxicologic Pathology|September 9, 2008
Histopathology of vascular injury in Sprague-Dawley rats treated with phosphodiesterase IV inhibitor SCH 351591 or SCH 534385Jun Zhang, Ronald D Snyder, Eugene H Herman, et al.
Pharmaceutical Research|October 22, 2003
Assessment of temporal biochemical and gene transcription changes in rat liver cytochrome P450: utility of real-time quantitative RT-PCRFederico M Goodsaid, Jairam R Palamanda, Diana Montgomery, et al.
Toxicologic Pathology|September 9, 2008
Biomarkers in peripheral blood associated with vascular injury in Sprague-Dawley rats treated with the phosphodiesterase IV inhibitors SCH 351591 or SCH 534385James L Weaver, Ronald Snyder, Alan Knapton, et al.
Nature Biotechnology|October 25, 2006
Rat toxicogenomic study reveals analytical consistency across microarray platformsLei Guo, Edward K Lobenhofer, Charles Wang, et al.
BMC Bioinformatics|July 20, 2005
Microarray scanner calibration curves: characteristics and implicationsLeming Shi, Weida Tong, Zhenqiang Su, et al.
BMC Bioinformatics|July 20, 2005
Cross-platform comparability of microarray technology: intra-platform consistency and appropriate data analysis procedures are essentialLeming Shi, Weida Tong, Hong Fang, et al.
The AAPS Journal|March 31, 2011
Translational biomarkers: from preclinical to clinical a report of 2009 AAPS/ACCP Biomarker WorkshopJane P F Bai, Robert Bell, ShaAvhree Buckman, et al.
Nature Biotechnology|September 12, 2006
Evaluation of DNA microarray results with quantitative gene expression platformsRoger D Canales, Yuling Luo, James C Willey, et al.
Nature Reviews. Drug Discovery|June 2, 2010
Voluntary exploratory data submissions to the US FDA and the EMA: experience and impactFederico M Goodsaid, Shashi Amur, Jiri Aubrecht, et al.
BMC Bioinformatics|September 20, 2008
The balance of reproducibility, sensitivity, and specificity of lists of differentially expressed genes in microarray studiesLeming Shi, Wendell D Jones, Roderick V Jensen, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Toxicologic Pathology|September 9, 2008
Histopathology of vascular injury in Sprague-Dawley rats treated with phosphodiesterase IV inhibitor SCH 351591 or SCH 534385Jun Zhang, Ronald D Snyder, Eugene H Herman, et al.
Pharmaceutical Research|October 22, 2003
Assessment of temporal biochemical and gene transcription changes in rat liver cytochrome P450: utility of real-time quantitative RT-PCRFederico M Goodsaid, Jairam R Palamanda, Diana Montgomery, et al.
Toxicologic Pathology|September 9, 2008
Biomarkers in peripheral blood associated with vascular injury in Sprague-Dawley rats treated with the phosphodiesterase IV inhibitors SCH 351591 or SCH 534385James L Weaver, Ronald Snyder, Alan Knapton, et al.
Nature Biotechnology|October 25, 2006
Rat toxicogenomic study reveals analytical consistency across microarray platformsLei Guo, Edward K Lobenhofer, Charles Wang, et al.
BMC Bioinformatics|July 20, 2005
Microarray scanner calibration curves: characteristics and implicationsLeming Shi, Weida Tong, Zhenqiang Su, et al.
BMC Bioinformatics|July 20, 2005
Cross-platform comparability of microarray technology: intra-platform consistency and appropriate data analysis procedures are essentialLeming Shi, Weida Tong, Hong Fang, et al.
The AAPS Journal|March 31, 2011
Translational biomarkers: from preclinical to clinical a report of 2009 AAPS/ACCP Biomarker WorkshopJane P F Bai, Robert Bell, ShaAvhree Buckman, et al.
Nature Biotechnology|September 12, 2006
Evaluation of DNA microarray results with quantitative gene expression platformsRoger D Canales, Yuling Luo, James C Willey, et al.
Nature Reviews. Drug Discovery|June 2, 2010
Voluntary exploratory data submissions to the US FDA and the EMA: experience and impactFederico M Goodsaid, Shashi Amur, Jiri Aubrecht, et al.
BMC Bioinformatics|September 20, 2008
The balance of reproducibility, sensitivity, and specificity of lists of differentially expressed genes in microarray studiesLeming Shi, Wendell D Jones, Roderick V Jensen, et al.
Pageof 3